RESULTS OF PHASE 2B EAGLE TRIAL; A DOUBLE BLIND PLACEBO CONTROL STUDY EVALUATING THE EFFICACY AND SAFETY OF BL-1020, A GABA ENHANCED ANTIPSYCHOTIC FOR THE TREATMENT OF SCHIZOPHRENIA
Publication
, Conference
Geffen, Y; Anand, R; Keefe, R; Davidson, M
Published in: Schizophrenia Research
April 2010
Duke Scholars
Published In
Schizophrenia Research
DOI
ISSN
0920-9964
Publication Date
April 2010
Volume
117
Issue
2-3
Start / End Page
212 / 212
Publisher
Elsevier BV
Related Subject Headings
- Psychiatry
- 3202 Clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Geffen, Y., Anand, R., Keefe, R., & Davidson, M. (2010). RESULTS OF PHASE 2B EAGLE TRIAL; A DOUBLE BLIND PLACEBO CONTROL STUDY EVALUATING THE EFFICACY AND SAFETY OF BL-1020, A GABA ENHANCED ANTIPSYCHOTIC FOR THE TREATMENT OF SCHIZOPHRENIA. In Schizophrenia Research (Vol. 117, pp. 212–212). Elsevier BV. https://doi.org/10.1016/j.schres.2010.02.296
Geffen, Yona, Ravi Anand, Richard Keefe, and Michael Davidson. “RESULTS OF PHASE 2B EAGLE TRIAL; A DOUBLE BLIND PLACEBO CONTROL STUDY EVALUATING THE EFFICACY AND SAFETY OF BL-1020, A GABA ENHANCED ANTIPSYCHOTIC FOR THE TREATMENT OF SCHIZOPHRENIA.” In Schizophrenia Research, 117:212–212. Elsevier BV, 2010. https://doi.org/10.1016/j.schres.2010.02.296.
Geffen Y, Anand R, Keefe R, Davidson M. RESULTS OF PHASE 2B EAGLE TRIAL; A DOUBLE BLIND PLACEBO CONTROL STUDY EVALUATING THE EFFICACY AND SAFETY OF BL-1020, A GABA ENHANCED ANTIPSYCHOTIC FOR THE TREATMENT OF SCHIZOPHRENIA. In: Schizophrenia Research. Elsevier BV; 2010. p. 212–212.
Geffen, Yona, et al. “RESULTS OF PHASE 2B EAGLE TRIAL; A DOUBLE BLIND PLACEBO CONTROL STUDY EVALUATING THE EFFICACY AND SAFETY OF BL-1020, A GABA ENHANCED ANTIPSYCHOTIC FOR THE TREATMENT OF SCHIZOPHRENIA.” Schizophrenia Research, vol. 117, no. 2–3, Elsevier BV, 2010, pp. 212–212. Crossref, doi:10.1016/j.schres.2010.02.296.
Geffen Y, Anand R, Keefe R, Davidson M. RESULTS OF PHASE 2B EAGLE TRIAL; A DOUBLE BLIND PLACEBO CONTROL STUDY EVALUATING THE EFFICACY AND SAFETY OF BL-1020, A GABA ENHANCED ANTIPSYCHOTIC FOR THE TREATMENT OF SCHIZOPHRENIA. Schizophrenia Research. Elsevier BV; 2010. p. 212–212.
Published In
Schizophrenia Research
DOI
ISSN
0920-9964
Publication Date
April 2010
Volume
117
Issue
2-3
Start / End Page
212 / 212
Publisher
Elsevier BV
Related Subject Headings
- Psychiatry
- 3202 Clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences